FDA approved Tessie (tasipimidine oral solution) for the treatment of noise aversion and separation anxiety in dogs, calling it the first approved treatment for both conditions in dogs.
Three quick summaries of the same article, tailored for different readers.
FDA’s approval of Tessie gives dog owners a new reason to talk with their veterinarian about fear-based behavior rather than simply living around it. Noise aversion and separation anxiety can look like barking, pacing, destruction, hiding, panting, or panic during storms, fireworks, traffic noise, or departures. The approval does not mean every worried dog needs medication, and it does not replace behavior modification. It does make one point clearer: severe fear deserves a real medical conversation. Owners who have been blaming themselves or assuming the dog is “being bad” may benefit from reframing the issue as anxiety that can be assessed, managed, and monitored.
Good source if you want the exact labeled indication and product context.For vet techs, this approval matters because behavior medication questions often show up as phone calls, refill requests, travel questions, and urgent pre-holiday worries. Tessie’s label gives teams a concrete reference point when explaining that noise aversion and separation anxiety are fear-based conditions, not obedience failures. It also reinforces why history matters: trigger type, onset, duration, escape attempts, appetite, sedation response, concurrent medications, and owner expectations all shape the veterinarian’s plan. The practical team role is helping families understand that medication may reduce panic, but it still belongs alongside environmental planning, training support, and follow-up.
Worth reading before client questions turn into fireworks-week emergencies.For pre-vet readers, Tessie is useful because it puts behavior medicine into a regulatory and clinical frame. Noise aversion and separation anxiety overlap in the owner’s experience—panic, vocalization, destruction, inability to settle—but they are not identical problems. A labeled product for both conditions raises the right questions: what endpoints were used, how safety was evaluated, how behavior modification remains part of management, and how clinicians separate situational fear from broader anxiety disorders. The larger lesson is that behavior cases require medical reasoning, not just temperament labels.
Read it for a concrete example of labeled behavior-medicine decision making.